Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus

M D de Kruif*, M Limper, H R Hansen, J de Ruiter, C A Spek, E C M van Gorp, I J ten Berge, A T Rowshani, H ten Cate, E W Meesters

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1654
JournalAnnals of the Rheumatic Diseases
Volume68
Issue number10
DOIs
Publication statusPublished - Oct 2009

Keywords

  • C-Reactive Protein/metabolism
  • Cross-Over Studies
  • Fluorobenzenes/therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
  • Lipids/blood
  • Lupus Erythematosus, Systemic/drug therapy
  • Pyrimidines/therapeutic use
  • Rosuvastatin Calcium
  • Sulfonamides/therapeutic use

Cite this